Biophysical Analysis, Novo Nordisk A/S, Novo Nordisk Park 1, 2760 Måløv, Denmark; Department of Pharmacy and Nanoscience Center, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.
Biophysical Analysis, Novo Nordisk A/S, Novo Nordisk Park 1, 2760 Måløv, Denmark; Department of Pharmacy and Nanoscience Center, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.
Eur J Pharm Biopharm. 2022 Oct;179:147-155. doi: 10.1016/j.ejpb.2022.08.018. Epub 2022 Sep 1.
Protein aggregates are often varying extensively in their morphological characteristics, which may lead to various biological outcomes, such as increased immunogenicity risk. However, isolation of aggregates with a specific morphology within an ensemble is often challenging. To gain vital knowledge on the effects of aggregate characteristics, samples containing a single morphology must be produced by direct control of the aggregation process. Moreover, the formed aggregates need to be in an aqueous solution suitable for biological assays, while keeping their morphology intact. Here we evaluated the dependence of morphology and integrity of amyloid-like fibrils and spherulites on preparation conditions and post-treatment methods. Samples containing either amyloid-like fibrils or spherulites produced from human insulin in acetic acid solutions are dependent on the presence of salt (NaCl). Moreover, mechanical shaking (600 rpm) inhibits spherulite formation, while only affecting the length of the formed fibrils compared to quiescent conditions. Besides shaking, the initial protein concentration in the formulation was found to control fibril length. Surprisingly, exchanging the solution used for aggregate formation to a physiologically relevant buffer, had a striking effect on the morphological integrity of the fibril and spherulite samples. Especially the secondary structure of one of our spherulite samples presented dramatic changes of the aggregated β-sheet content after exchanging the solution, emphasizing the importance of the aggregate stability. These results and considerations have profound implications on the data interpretation and should be implemented in the workflow for both fundamental characterization of aggregates as well as assays for evaluation of their corresponding biological effects.
蛋白质聚集体在形态特征上往往差异很大,这可能导致各种生物学后果,例如增加免疫原性风险。然而,在混合物中分离具有特定形态的聚集体通常具有挑战性。为了深入了解聚集体特征的影响,必须通过直接控制聚合过程来产生具有单一形态的样品。此外,形成的聚集体需要处于适合生物测定的水溶液中,同时保持其形态完整。在这里,我们评估了类淀粉样纤维和球晶的形态和完整性对制备条件和后处理方法的依赖性。在醋酸溶液中由人胰岛素产生的含有类淀粉样纤维或球晶的样品依赖于盐(NaCl)的存在。此外,机械搅拌(600rpm)抑制球晶形成,而与静置条件相比,仅影响形成的纤维的长度。除了搅拌之外,制剂中初始蛋白质浓度被发现控制纤维长度。令人惊讶的是,将用于聚集体形成的溶液交换为生理相关的缓冲液,对纤维和球晶样品的形态完整性有显著影响。特别是我们的一个球晶样品的二级结构在交换溶液后,聚集的β-折叠含量发生了剧烈变化,强调了聚集体稳定性的重要性。这些结果和考虑对数据解释具有深远的影响,应该在用于评估其相应生物学效应的聚集物的基本特性描述以及测定工作流程中实施。